Co-development Programs
Novel gene-based therapies and technologies
Key Facts
About Moligo Technologies
Moligo Technologies is a private, Stockholm-based biotech providing high-purity, long single-stranded DNA (ssDNA) as a critical reagent for next-generation genetic medicine and research. The company's core innovation is a patented Enzymatic Injection Molding technology that overcomes the length, purity, and scalability limitations of traditional chemical DNA synthesis and fermentation methods. Moligo operates primarily as a platform and service provider, supplying custom ssDNA to partners in gene therapy and CRISPR while also engaging in co-development programs. Backed by family offices and specialist healthcare investors, the company is positioned to enable a new class of DNA-based tools and therapies.
View full company profile